A CXCR4‐Targeted Site‐Specific Antibody–Drug Conjugate
Sumith A. Kularatne(Scripps Research Institute), Peter G. Schultz(Scripps Research Institute), Stephanie A. Kazane(California Institute for Biomedical Research), Brunhilde Felding‐Habermann(Scripps Research Institute), Aaron Sellers(Torrey Pines Institute For Molecular Studies), Tsotne Javahishvili(Torrey Pines Institute For Molecular Studies), Reyna K. V. Lim(California Institute for Biomedical Research), Anthony Manibusan(Ambrx (United States)), Shailaja Srinagesh(Torrey Pines Institute For Molecular Studies), Virginie Tardif(Inserm), Jane Forsyth, Ying Sun(Central South University), Feng Tian(Torrey Pines Institute For Molecular Studies), Jennifer Ma(California Institute for Biomedical Research), V. Deshmukh(Samumed (United States)), Brian R. Lawson(Scripps Research Institute), Holly Pugh(California Institute for Biomedical Research), Richard S. Barnett(Torrey Pines Institute For Molecular Studies), Wolf Hassenpflug(Scripps Research Institute)
Cited by 66
Related Papers
Organization of 'nanocrystal molecules' using DNA
|Nature|1996|3k
Contribution of platelets to tumour metastasis
|Nature reviews. Cancer|2011|1.6k
Genomic analysis of the host response to hepatitis C virus infection
|Proceedings of the National Academy of Sciences|2002|1.2k
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833